Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breath tests to phenotype drug disposition in oncology.

Clinical pharmacokinetics - 1 Nov 2013

Opdam Frans L, Modak Anil S, Gelderblom Hans, Guchelaar Henk-Jan

Abstract excerpt

Breath tests (BTs) have been investigated as diagnostic tools to phenotype drug disposition in cancer patients in the pursuit to individualize drug treatment. The choice of the right phenotype probe is crucial and depends on the metabolic pathway of the anticancer agent of interest. BTs using orally or intravenously administered selective non-radioactive (13)C-labeled probes to non-invasively evaluate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Pyridinylmethylsulfinylbenzimidazoles
Share to Antineoplastic Agents
Share to Breath Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Dextromethorphan

Share to Dihydrouracil Dehydrogenase (NADP)

Share to Erythromycin

Share to Uracil

Source

Identifiers

PMID: 23868281
DOI: 10.1007/s40262-013-0099-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breath tests to phenotype drug disposition in oncology.PMID 23868281Read ↗

Further characterization of a ¹³C-dextromethorphan breath test for CYP2D6 phenotyping in breast cancer patients on tamoxifen therapy.Semantic proximity Read ↗

Phenotyping drug disposition in oncology.Semantic proximity Read ↗

The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.Semantic proximity Read ↗

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug MetabolismSemantic proximity Read ↗

Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature.Semantic proximity Read ↗

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.Semantic proximity Read ↗

(13)C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients.Semantic proximity Read ↗

The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil.Semantic proximity Read ↗

Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.Semantic proximity Read ↗

Dextromethorphan oxidation phenotypes as markers for susceptibility to lung cancer.Semantic proximity Read ↗

Evaluation of a [13C]-dextromethorphan breath test to assess CYP2D6 phenotype.Semantic proximity Read ↗

Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.